menu
    • menu

    Company profile for Capstan Therapeutics

    NEW Drugs in Dev.: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Capstone Therapeutics Corp. (the “Company” or “we”), is traded on the OTCQB under the ticker symbol “CAPS”. The Company has three assets that are being utilized in efforts to create shareholder value: (1) ownership of a wholly-owned subsidiary, TotalStone, LLC, which distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States; (2) ownership of a minorit...
    Capstone Therapeutics Corp. (the “Company” or “we”), is traded on the OTCQB under the ticker symbol “CAPS”. The Company has three assets that are being utilized in efforts to create shareholder value: (1) ownership of a wholly-owned subsidiary, TotalStone, LLC, which distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States; (2) ownership of a minority interest in Diamond Products Holdings, LLC, a sexual wellness products holding company with worldwide sales.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Capstan TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1275 West Washington Street Suite 104 Tempe, AZ 85281
    Telephone
    Telephone
    800.937.5520
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.capstonethx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcturus Sues AbbVie Over Drug-Delivery Trade Secrets
    Arcturus Sues AbbVie Over Drug-Delivery Trade Secrets

    24 Sep 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/arcturus-sues-abbvie-over-drug-delivery-trade-secrets-2025-09-23/

    REUTERS
    24 Sep 2025
    Share Share
    AbbVie Completes Acquisition of Capstan Therapeutics
    AbbVie Completes Acquisition of Capstan Therapeutics

    20 Aug 2025

    // PRESS RELEASE

    https://news.abbvie.com/2025-08-19-AbbVie-Completes-Acquisition-of-Capstan-Therapeutics

    PRESS RELEASE
    20 Aug 2025
    Share Share
    AbbVie to buy Capstan for up to $2.1B in Immunology Push
    AbbVie to buy Capstan for up to $2.1B in Immunology Push

    01 Jul 2025

    // PRESS RELEASE

    https://news.abbvie.com/2025-06-30-AbbVie-to-Acquire-Capstan-Therapeutics,-Further-Strengthening-Commitment-to-Transforming-Patient-Care-in-Immunology

    PRESS RELEASE
    01 Jul 2025
    Share Share
    Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Au
    Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Au

    11 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250611668181/en/Capstan-Therapeutics-Announces-Initiation-of-Phase-1-Trial-of-Lead-In-Vivo-CAR-T-Therapy-CPTX2309-for-Treating-Autoimmune-Disease

    BUSINESSWIRE
    11 Jun 2025
    Share Share
    Capstan collects $110M for robotic heart valve replacement
    Capstan collects $110M for robotic heart valve replacement

    11 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/capstan-medical-collects-110m-robotic-heart-valve-replacements

    FIERCE BIOTECH
    11 Dec 2024
    Share Share
    Capstan Presents Preclinical Data on CPTX2309 CAR-T at ACR 2024
    Capstan Presents Preclinical Data on CPTX2309 CAR-T at ACR 2024

    18 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118858480/en

    BUSINESSWIRE
    18 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search